Download GSK Asthma Virtual Assistant APK latest version Free for Android
| Version | 1.1.0 |
| Update | 1 year ago |
| Size | 17.70 MB (18,563,847 bytes) |
| Developer | Glaxo SmithKline PLC |
| Category | Apps, Medical |
| Package Name | com.gsk.ava.ph |
| OS | 6.0 and up |
GSK Asthma Virtual Assistant APPLICATION description
A tool to help remind, educate and monitor asthma control
GSK AVA intends to provide asthma patients in the Philippines with: (1) daily reminders to take their Salmeterol + Fluticasone propionate (Seretide) inhaler medication, (2) access to basic information about asthma, and (3) a feature to monitor asthma control.
GSK AVA BENEFITS:
The GSK AVA can help patients prescribed with a Salmeterol + Fluticasone propionate (Seretide) inhaler adhere to their prescription and monitor their asthma control through:
- Increased understanding of bronchial asthma via educational materials about the disease and its treatment.
- Increased understanding of proper inhaler device techniques via instructional videos on how to use the Diskus and metered dose inhaler devices.
- Daily reminder functionality, with alarms that patients can set, to lessen forgetfulness that lead to missed doses, ultimately improving adherence.
- Improved understanding and monitoring of patient's asthma control through the Asthma Control Test, with scores recorded and progress monitored monthly
Note: The use of GSK AVA requires an activation code which can be provided by your medical doctor along with your Salmeterol + Fluticasone propionate (Seretide) prescription. To gain access to the GSK AVA, please approach your medical doctor.
IMPORTANT: The GSK Asthma Virtual Assistant (AVA) is an app designed for patients prescribed with Salmeterol + Fluticasone propionate (Seretide). The use of the GSK AVA with other inhalers or asthma medication is not recommended. The GSK AVA does not serve as a substitute for medical doctor consultations. It is also not a medical device. It is not designed to diagnose, prevent, monitor, treat or alleviate asthma or any respiratory diseases. If you wish to be diagnosed, please visit a medical doctor. The GSK AVA cannot detect an asthma attack or exacerbation. If you experience chest pain, worsening cough and shortness of breath, please visit a healthcare facility or call emergency services immediately.
FOR PHILIPPINE PATIENTS ONLY
Kindly forward all adverse events and product complaints to GSK Philippines via these contact details:
ADVERSE EVENTS: [email protected]
PRODUCT COMPLAINTS: [email protected] or (0917) 889 7050
Trademarks are owned by or licensed to the GSK group of companies.
©2022 GSK group of companies or its licensor. All rights reserved.
GlaxoSmithKline Philippines Inc
23F The Finance Centre, 26th St. cor. 9th Ave.
Bonifacio Global City, Taguig City
Tel. No.: (632) 8892-0761
NP-PH-FPS-MBAN-220002 | February 2022
GSK AVA BENEFITS:
The GSK AVA can help patients prescribed with a Salmeterol + Fluticasone propionate (Seretide) inhaler adhere to their prescription and monitor their asthma control through:
- Increased understanding of bronchial asthma via educational materials about the disease and its treatment.
- Increased understanding of proper inhaler device techniques via instructional videos on how to use the Diskus and metered dose inhaler devices.
- Daily reminder functionality, with alarms that patients can set, to lessen forgetfulness that lead to missed doses, ultimately improving adherence.
- Improved understanding and monitoring of patient's asthma control through the Asthma Control Test, with scores recorded and progress monitored monthly
Note: The use of GSK AVA requires an activation code which can be provided by your medical doctor along with your Salmeterol + Fluticasone propionate (Seretide) prescription. To gain access to the GSK AVA, please approach your medical doctor.
IMPORTANT: The GSK Asthma Virtual Assistant (AVA) is an app designed for patients prescribed with Salmeterol + Fluticasone propionate (Seretide). The use of the GSK AVA with other inhalers or asthma medication is not recommended. The GSK AVA does not serve as a substitute for medical doctor consultations. It is also not a medical device. It is not designed to diagnose, prevent, monitor, treat or alleviate asthma or any respiratory diseases. If you wish to be diagnosed, please visit a medical doctor. The GSK AVA cannot detect an asthma attack or exacerbation. If you experience chest pain, worsening cough and shortness of breath, please visit a healthcare facility or call emergency services immediately.
FOR PHILIPPINE PATIENTS ONLY
Kindly forward all adverse events and product complaints to GSK Philippines via these contact details:
ADVERSE EVENTS: [email protected]
PRODUCT COMPLAINTS: [email protected] or (0917) 889 7050
Trademarks are owned by or licensed to the GSK group of companies.
©2022 GSK group of companies or its licensor. All rights reserved.
GlaxoSmithKline Philippines Inc
23F The Finance Centre, 26th St. cor. 9th Ave.
Bonifacio Global City, Taguig City
Tel. No.: (632) 8892-0761
NP-PH-FPS-MBAN-220002 | February 2022
↓ Read more
Old versions
| Version | Size | Update |
|---|---|---|
| ⇢ 1.1.0 (3 variants) | ↓ 17.54 MB | ◴ 1 year ago |
